Exane Derivatives’s Arcosa ACA Stock Holding History

Exane Derivatives’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-144	Closed	-$6.08K	–	752
2020 Q2	$6.08K	Hold	144	–	–	﹤0.01%	438
2020 Q1	$5.72K	Hold	144	–	–	﹤0.01%	450
2019 Q4	$6.7K	Hold	144	–	–	﹤0.01%	422
2019 Q3	$4.92K	Hold	144	–	–	﹤0.01%	453
2019 Q2	$5.42K	Buy	+144	New	+$4.92K	﹤0.01%	469
2019 Q1	–	Sell	-144	Closed	-$3.99K	–	640
2018 Q4	$3.99K	Buy	+144	New	+$3.96K	﹤0.01%	501

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's ACA Position: Q3 2020 in Review

Exane Derivatives sold out of Arcosa (ACA) in Q3 2020, closing a stake of 144 shares — an estimated $6.08K sold.

Exane Derivatives first reported a position in ACA in Q4 2018 and held it in 6 quarters. The position peaked at $6.7K in Q4 2019. 256 funds tracked by Wall St. Rank hold ACA as of Q3 2020.

Exane Derivatives reported no remaining Arcosa position as of Q3 2020 after selling out during the quarter.
Exane Derivatives sold 144 Arcosa shares in Q3 2020, an estimated $6.08K.
Exane Derivatives first reported a position in Arcosa in Q4 2018 and held it in 6 quarters.
Exane Derivatives's Arcosa position peaked at $6.7K in Q4 2019.
256 funds tracked by Wall St. Rank held Arcosa as of Q3 2020.

Based on Exane Derivatives's 13F filing for Q3 2020, filed 6 Oct 2020.